Synonyms: example 51 [WO2013090664A1] | GSK-2838232 | GSK-8232 | GSK232
Compound class:
Synthetic organic
Comment: GSK2838232 is an investigational HIV maturation inhibitor [2-3]. This class of compounds bind to the HIV-1 gag protein and disrupt its cleavage by the viral protease that is crucial for forming new mature and infectious virus particles [4,6]. This mechanism is proposed to maintain antiviral efficacy against drug-resistant strains of HIV-1.
|
|
No information available. |
Summary of Clinical Use ![]() |
A phase 2 study of GSK2838232 has been completed |
Clinical Trials | |||||
Clinical Trial ID | Title | Type | Source | Comment | References |
NCT03045861 | Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults | Phase 2 Interventional | GlaxoSmithKline | 1 |